Ryusuke Koshida

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Venues

Journal of diabetes investigation

Expert opinion on pharmacotherapy

Diabetes, obesity & metabolism

Sanofi Japan

University of Tsukuba (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sanofi Japan May 20 2019

Japan

Medical Science Liaison/Diabetes Medical Lead :: Primary Care Medical Operations

CMIC Ashfield Co., Ltd Apr 01 2019

Japan

Medical Science Liaison :: Medical Affairs Business Unit

University of Tsukuba Apr 01 2016 - Mar 31 2019

Japan

Assistant Professor

University of Tsukuba Hospital Apr 01 2010 - Mar 31 2012

Japan

Resident physician

Education History

University of Tsukuba Apr 01 2012 - Mar 31 2016

Japan

PHD :: Medicine

Publications

Hideaki Kaneto, Ryusuke Koshida, Mike Baxter
Fixed-ratio combination of basal insulin and glucagon-like peptide-1 receptor agonists in the treatment of Japanese people with type 2 diabetes: An innovative solution to a complex therapeutic challenge. Diabetes, obesity & metabolism (2021)
Kazunori Utsunomiya, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, Ryusuke Koshida, Hiroyuki Kameda, Masahiro Tamura, Kohei Kaku
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus: Results of 24-month interim analysis of a long-term post-marketing study (J-STEP/LT). Journal of diabetes investigation 11 (4) (2020)
Munehide Matsuhisa, Masato Odawara, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi
Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study). Expert opinion on pharmacotherapy 22 (2) (2020)
Masato Odawara, Munehide Matsuhisa, Takahisa Hirose, Ryusuke Koshida, Masayuki Senda, Yasushi Tanaka, Yasuo Terauchi
Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study). Expert opinion on pharmacotherapy 21 (14) (2020)
Kazunori Utsunomiya, Ryusuke Koshida, Seigo Kakiuchi, Masayuki Senda, Shoko Fujii, Yuji Kurihara, Ryoji Gunji, Kohei Kaku
Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus treated in real-world clinical practice: Results of a 36-month post-marketing surveillance study (J-STEP/LT). Journal of diabetes investigation 12 (2) (2020)

Ryusuke Koshida.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ryusuke Koshida